APTN
Adaptin Bio, Inc.
$6.22
+0.02 (+0.32%)
At close · Jun 29
Going-concern doubt
— flagged May 15, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Management has evaluated the Company’s operating plan against its existing cash and determined that substantial doubt exists about the Company’s ability to support its operations and fund its obligations for the next twelve months from the date of issuance of these condensed consolidated financial statements.”View the 10-Q filed May 15, 2026
Shares
8,903,229
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 10-K/A | 2026-06-12 | 2025-12-31 | |
| 10-Q | 2026-05-15 | 2026-03-31 | |
| 8-K | 2026-04-06 | — | |
| 10-K | 2026-04-01 | 2025-12-31 | |
| 8-K | 2025-12-23 | 2025-12-22 | |
| 10-Q | 2025-11-14 | 2025-09-30 | |
| 8-K | 2025-10-06 | 2025-10-03 | |
| 10-Q | 2025-08-14 | 2025-06-30 | |
| 10-Q | 2025-05-15 | 2025-03-31 | |
| 10-K | 2025-04-15 | 2024-12-31 | |
| 8-K/A | 2025-04-15 | 2025-02-11 | |
| 8-K | 2025-04-09 | 2025-04-07 | |
| 8-K | 2025-02-18 | 2025-02-11 | |
| 10-Q | 2024-11-14 | 2024-09-30 | |
| 10-Q | 2024-08-14 | 2024-06-30 | |
| 10-Q | 2024-05-15 | 2024-03-31 | |
| 10-K | 2024-04-01 | 2023-12-31 | |
| 10-Q | 2023-11-14 | 2023-09-30 |
Showing 1–18 of 18 filings